Accord Healthcare Inc, the US arm of Intas Pharmaceuticals, is recalling over 46,000 bottles of Hydrochlorothiazide tablets manufactured by the Ahmedabad-based firm, on account of labelling mix-up, USFDA said.
Accord Healthcare is recalling 46,632 bottles of Hydrochlorothiazide tablets USP in the strength of 12.5 mg, the Enforcement Report by United States Food and Drug Administration (USFDA) said.
The reason for the recall is "Labelling: label mix-up: customer complaint that a sealed bottle labelled as 12.5 mg contained only Spironolactone tablets USP 25 mg," it added.
The voluntary nationwide recall in the US and Puerto Rico has not been classified yet, the report said.